Wilkin, Kathryn
Evans, Subhadra
Van Niekerk, Leesa
Romano, Daniel
Fuller-Tyszkiewicz, Matthew
Knowles, Simon
Chesterman, Susan
Raven, Leanne
Mikocka-Walus, Antonina http://orcid.org/0000-0003-4864-3956
Funding for this research was provided by:
Crohn's and Colitis Foundation of America (828660)
Deakin University
Article History
Accepted: 15 December 2023
First Online: 12 February 2024
Declarations
:
: Kathryn Wilkin, Subhadra Evans, Leesa Van Niekerk, Daniel Romano, Matthew Fuller-Tyszkiewicz, Simon Knowles, Susan Chesterman, Leanne Raven, and Antonina Mikocka-Walus do not have any conflict of interest in relation to the present study; however, outside this work, Simon Knowles has served as an educational speaker for Janssen, Ferring, and Takeda. Antonina Mikocka-Walus has served as an educational speaker for Janssen and Ferring.
: Ethics approval was obtained from the Deakin University Research Ethics Committee in September 2021 (Ref. 2021-263) and the New Zealand Central Health and Disability Ethics Committee in December 2021 (Ref. 2021 EXP 11384). The registration number associated with the trial is ACTRN12621001316897.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study. Verbal informed consent was obtained prior to the interview. Participants signed informed consent regarding publishing their data.